ImmunityBio, Inc. IBRX

The only reason a professional money manager, analyst, hedge fund mutual fund ETF managers would ever watch CNBC or FoxBusiness Mad Money is to see if they are spinning the stories as instructed...............

Paul Silberberg $1000 for your thoughts only person that I value on this board

Will buy more once under $7

Paul Silberberg would love to hear your thoughts

Mine are simple nothing has changed and in 1 year ImmunityBio will have become profitable and the stock will be $25-$50 maybe even higher

Glad I sold few days ago

Panda0000

Go ? you must work for Merck Keytruda is finished

Saudi Arabia is going to create a cancer treatment center for all of the Middle East. They will have continual large standing orders Anktiva BioShield and they will be making NK T cells there

My explanation would be. It's an investment, not a spec. Many times after earnings and earnings calls stocks trade down on profit-sharing. Then they rise in the next quarter heading to the next earnings in anticipation of increase sales and revenues and profitability. We have a additional catalyst called approval expanded use of Anktiva bioshield NK killer
T cells! I think ImmunityBio will show a profit for quarter 2026 or first quarter 2027!

Long answer so today's price movement is irrelevant other than it's post earnings post earnings call and many traders sell and try to market time. My advice is don't market time you may be out when Big news is released.

I have seen zero chance for weeks now that IBRX ever goes way down. IBRX has morphed from a spec to a stock investment that will show rapid sales growth and rapid earnings growth and become profitable.

Answer, please from someone if this trading is related to shorts when do you think it will end?